Previous 10 | Next 10 |
Below are the five companies in the Health Care Services industry with the highest forward earnings yields. Using projected earnings for the current fiscal year, the forward earnings yield is useful to compare a stock's return vs. owning a similar stock or other yield assets (e.g. bonds). Gene...
FLINT, Mich. , Oct. 2, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), has appointed David Skomo as chief operating officer of CastiaRx following the retirement of Chris Luthin . CastiaRx, a division of Diplomat, is a pharmacy benefit manager (PBM) that helps hea...
Deutsche Bank's George Hill updates his ratings on the healthcare services space: More news on: CVS Health Corporation, Anthem, Inc., Cigna Corporation, Healthcare stocks news, , Read more ...
Diplomat Pharmacy, Inc. (DPLO) Q2 2019 Earnings Conference Call August 9, 2019 08:30 AM ET Company Participants Terri Anne Powers – Vice President of Investor Relations Brian Griffin – Chairman and Chief Executive Officer Dan Davison – Chief Financial Officer...
The following slide deck was published by Diplomat Pharmacy, Inc. in conjunction with their 2019 Q2 earnings Read more ...
Diplomat Pharmacy ( DPLO ) Q2 results : Revenues: $1,287.6M (-9.1%); Specialty segment: $1,215.8M (-1.5%); PBM segment: $90.3M (-52.1%). More news on: Diplomat Pharmacy, Inc., Healthcare stocks news, Earnings news and commentary, Stocks on the move, Read more ...
Diplomat Pharmacy (NYSE: DPLO ): Q2 GAAP EPS of -$2.13 misses by $1.94 . More news on: Diplomat Pharmacy, Inc., Earnings news and commentary, Stocks on the move, Healthcare stocks news, Read more ...
FLINT, Mich. , Aug. 9, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation's largest independent provider of specialty pharmacy and infusion services, announced financial results for the quarter ended June 30, 2019 . All comparisons, unless otherwise noted, are to...
FLINT, Mich. , Aug. 9, 2019 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO) today announced that its Board of Directors is reviewing strategic alternatives. At the direction of its Board of Directors, the company is reviewing strategic alternatives focused...
Diplomat Pharmacy (NYSE: DPLO ) is scheduled to announce Q2 earnings results on Friday, August 9th, before market open. The consensus EPS Estimate is $0.07 (-58.8% Y/Y) and the consensus Revenue Estimate is $1.23B (-13.4% Y/Y). Over the last 2 years, DPLO has beaten EPS estimates...
News, Short Squeeze, Breakout and More Instantly...
Diplomat Pharmacy Inc. Company Name:
DPLO Stock Symbol:
NYSE Market:
NEW YORK , Feb. 7, 2020 /PRNewswire/ -- S&P Dow Jones Indices will make the following changes to the S&P MidCap 400 and S&P SmallCap 600 effective prior to the open of trading on Thursday, February 13 : Generac Holdings Inc. (NYSE:GNRC) will replace Alexander & Ba...
Buyouts Can Be Big For Penny Stocks But Not In The Way You May Think Penny stocks hold a lot of potential especially if the company is an acquisition target. You always hear the stories of how someone who found a cheap penny stock to buy that ultimately was bought out for much more than in...
Shares of Diplomat Pharmacy (NYSE: DPLO) were down 32% at 11:44 a.m. EST today after the company announced that it's being acquired by OptumRx, UnitedHealth Group 's (NYSE: UNH) pharmacy-care services division. You read that right: The company is being acquired, and shares went dow...